Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia.

Nilius, Henning; Hamzeh-Cognasse, Hind; Hastings, Janna; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Greinacher, Andreas; Mendez, Adriana; Schmidt, Adrian Emanuel; Wuillemin, Walter A; Gerber, Bernhard; Vishnu, Prakash; Graf, Lukas; Kremer Hovinga, Johanna A; Bakchoul, Tamam; Cognasse, Fabrice; Nagler, Michael (2024). Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. (In Press). Blood advances American Society of Hematology 10.1182/bloodadvances.2024012782

[img] Text
bloodadvances.2024012782.pdf - Accepted Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB) | Request a copy

New analytical techniques can assess hundreds of proteins simultaneously with high sensitivity, facilitating the observation of their complex interplay and role in disease mechanisms. We hypothesized that proteomic profiling targeting proteins involved in thrombus formation, inflammation, and the immune response would identify potentially new biomarkers for heparin-induced thrombocytopenia (HIT). Four existing panels of the Olink proximity extension assay covering 356 proteins involved in thrombus formation, inflammation, and immune response were applied to randomly selected patients with suspected HIT (confirmed HIT, n=32; HIT ruled-out, n=38; positive heparin/PF4 [H/PF4] antibodies, n=28). The relative difference in protein concentration was analyzed using a linear regression model adjusted for sex and age. To confirm the test results, soluble P-selectin was determined using ELISA in above mentioned patients and an additional second dataset (n=49). HIT was defined as a positive heparin-induced platelet aggregation test (HIPA; washed platelet assay). Among 98 patients of the primary dataset, the median 4Ts score was 5 in patients with HIT, 4 in patients with positive heparin/PF4 antibodies, and 3 in patients without HIT. The median OD of a polyspecific heparin/PF4 ELISA was 3.0, 0.9, and 0.3, respectively. Soluble P-selectin remained statistically significant after multiple test adjustments. The area under the receiver-operating-characteristics-curve was 0.81 for Olink and 0.8 for ELISA. Future studies shall assess the diagnostic and prognostic value of soluble P-selectin in the management of HIT.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

Graduate School:

Graduate School for Health Sciences (GHS)

UniBE Contributor:

Nilius, Henning Jürgen Jean, Kremer Hovinga Strebel, Johanna Anna, Nagler, Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2473-9537

Publisher:

American Society of Hematology

Language:

English

Submitter:

Pubmed Import

Date Deposited:

09 Apr 2024 10:57

Last Modified:

10 Apr 2024 06:17

Publisher DOI:

10.1182/bloodadvances.2024012782

PubMed ID:

38588487

BORIS DOI:

10.48350/195791

URI:

https://boris.unibe.ch/id/eprint/195791

Actions (login required)

Edit item Edit item
Provide Feedback